Eli Lilly says Zepbound beat rival weight loss drug Wegovy in head-to-head study ...Middle East

Quartz - Economy
Eli Lilly says Zepbound beat rival weight loss drug Wegovy in head-to-head study
Zepbound is the “superior” choice for people looking to shed a few pounds, at least compared to Novo Nordisk’s (NVO) Wegovy, according to Eli Lilly (LLY). Read more...

Hence then, the article about eli lilly says zepbound beat rival weight loss drug wegovy in head to head study was published today ( ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Eli Lilly says Zepbound beat rival weight loss drug Wegovy in head-to-head study )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Economy


Latest News